← Open Payments lookup

CARLOS SALGUEIRO: Open Payments

NPI 1407914039 · WESTON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$5,017 in 195 payments from 18 companies in 2025. Trend: 2023 $2,123 · 2024 $2,539 · 2025 $5,017

Food & beverage: $5,017
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)29$963
Teva Pharmaceuticals USA, Inc.35$871
Alkermes, Inc.29$589
Janssen Pharmaceuticals, Inc15$376
Corium, LLC13$362
Otsuka America Pharmaceutical, Inc.13$331
Neurocrine BioSciences, Inc.6$256
Supernus Pharmaceuticals, Inc.8$225
Takeda Pharmaceuticals U.S.A., Inc.11$164
E.R. Squibb & Sons, L.L.C.7$157

Products named: CAPLYTA, ARISTADA, UZEDY, AUSTEDO XR, Azstarys, INVEGA SUSTENNA, REXULTI, INGREZZA.

Industry payments across FL — which companies pay providers there.